Zobrazeno 11 - 20
of 27
pro vyhledávání: '"Elia Sais"'
Autor:
Joan Brunet, Javier A. Menendez, Salvador Pedraza, Jordi Marruecos, Angel Izquierdo, Joaquim Bosch-Barrera, Manel Haro, Elisabet Cuyàs, Elia Sais, Noemí Cañete, Rut Porta
Publikováno v:
Oncotarget
Oncotarget, 2016, vol. 7, núm. 22, p. 32006-32014
Articles publicats (D-CM)
DUGiDocs – Universitat de Girona
instname
Recercat. Dipósit de la Recerca de Catalunya
Oncotarget, 2016, vol. 7, núm. 22, p. 32006-32014
Articles publicats (D-CM)
DUGiDocs – Universitat de Girona
instname
Recercat. Dipósit de la Recerca de Catalunya
// Joaquim Bosch-Barrera 1, 2, 3 , Elia Sais 1 , Noemi Canete 2, 4 , Jordi Marruecos 2, 5 , Elisabet Cuyas 2, 6 , Angel Izquierdo 1, 2, 3 , Rut Porta 1, 2, 3 , Manel Haro 2, 3, 7 , Joan Brunet 1, 2, 3 , Salvador Pedraza 2, 3, 4 , Javier A. Menendez 2
Autor:
Elia Sais, Joaquim Bosch-Barrera, E. Teixidor, Alfonso Calvo, Angel Izquierdo, V. Garriga, A. Hernandez, E. Cuyàs, M. Valiente, S. Pedraza, M. Puigdemont, J.A. Menendez, S. Verdura, N. Quer, D. Garcia, N. Priego, Joan Brunet, A. Carbó, A. Roselló
Publikováno v:
Journal of Thoracic Oncology. 14:S658
Autor:
R. Marse-Fabregat, J. Coves, Nuria Viñolas, Oscar Juan, M. Gil Moreno, L. Vila, Noelia Vilariño, A.M. Esteve Gomez, M. Cobo, A. Barba, R. Bernabé, R. Garcia Campelo, L. Angelats, V. Calvo De Juan, Elia Sais, Pedro Rocha, Sonia Argibay Vázquez, Edurne Arriola, Manuel Domine, Enric Carcereny
Publikováno v:
Journal of Thoracic Oncology. 14:S397
Autor:
Teresa, Morán, Eudald, Felip, Joaquim, Bosch-Barrera, Itziar, de Aguirre, Jose Luis, Ramirez, Carles, Mesia, Enric, Carcereny, Diana, Roa, Elia, Sais, Yolanda, García, Remei, Blanco, Silvia, Sanchez, Claudia Rosa, Villacorta, Cristina, Queralt, Jose María, Velarde, Rafael, Rosell
Publikováno v:
Oncotarget
Osimertinib is efficacious in lung cancer patients with epidermal growth factor receptor (Serum/plasma fromThirteen patients were included. Median time on osimertinib treatment was 10.6 months with a median progression-free survival of 13.6 months. B
Autor:
Cristina Toro Blanch, Joaquim Bosch-Barrera, Huber Gunter Mas Pueyo, Maria López Brunsó, Angel Izquierdo Font, Silvia Guerra Prió, Diana Roa García, Elia Sais Girona, Alejandro Hernández Martínez
Publikováno v:
Anti-cancer drugs. 29(4)
Drug-drug interactions (DDIs) are of great concern in the treatment of cancer, especially when target therapies, such as tyrosine kinase inhibitors, are being used. Here, we report a case of probable DDI between erlotinib and amiodarone leading to se
Autor:
Elia Sais, Eduard Teixidor, Joaquim Bosch-Barrera, Javier A. Menendez, Angel Izquierdo, Alejandro Hernández, Carmen Amalia Vásquez, Gloria Sánchez, Walter Carbajal, Sara Verdura
Publikováno v:
Oncotarget, 2018, vol. 9, núm. 68, p. 33043-33049
Articles publicats (D-CM)
Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo i Font, Àngel Xavier Verdura, Sara Menéndez Menéndez, Javier Abel Bosch Barrera, Joaquim 2018 Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Oncotarget 9 68 33043 33049
DUGiDocs – Universitat de Girona
instname
Articles publicats (D-CM)
Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo i Font, Àngel Xavier Verdura, Sara Menéndez Menéndez, Javier Abel Bosch Barrera, Joaquim 2018 Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Oncotarget 9 68 33043 33049
DUGiDocs – Universitat de Girona
instname
Advances in immunotherapy have changed the therapeutic landscape of non-small cell lung cancer (NSCLC), extending overall survival over standard chemotherapy. However, by removing the protection against autoimmunity, immunotherapy can increase immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4efc19ac58e9bdc40657af3096757eff
http://hdl.handle.net/10256/20783
http://hdl.handle.net/10256/20783
Autor:
E. Cuyàs, Jose Carlos Ruffinelli, S. Verdura, J.A. Menendez, Enric Carcereny, Elia Sais, Teresa Moran, Ernest Nadal, Ramon Palmero, Angel Izquierdo, J. Bosch Barrera
Publikováno v:
Journal of Thoracic Oncology. 13:S593-S594
Autor:
Noelia Vilariño, Maria Jove, Matilde Navarro, Conxi Lázaro, Mireia Gausachs, Gabriel Capellá, Ernest Nadal, Elia Sais, Joaquim Bosch-Barrera, Anna Estival, Ramon Palmero, Teresa Moran, Joan Brunet, Enric Carcereny Costa, Jose Carlos Ruffinelli, Angel Izquierdo, Alex Teulé, Claudia Fina
Publikováno v:
Journal of Clinical Oncology. 37:TPS9122-TPS9122
TPS9122 Background: Lung cancer (LC) is a rare disease among young adults. Polymorphisms in genes involved in carcinogenic metabolism of tobacco and/or xenobiotic metabolism have been identified in those patients. The growing use of next generation s
Autor:
V. Calvo De Juan, A.M. Esteve Gomez, M. Gil Moreno, A. Barba Joaquín, M.R. Garcia Campelo, E. Arriola Aperribay, O.J. Juan Vidal, M. Domine Gomez, Delvys Rodriguez-Abreu, L. Angelats, E. Carcereny Costa, M. Cobo, Elia Sais, R. Marse Fabregat, N. Vilariño Quintela, J. Coves Sarto, N. Vinolas Segarra, N. Fernandez Nuñez, L. Vilà Martinez, R. Bernabe Caro
Publikováno v:
Annals of Oncology. 30:ii53
Autor:
Carol Lorencio, Joan Brunet, Elia Sais, Rut Porta, Joaquim Bosch-Barrera, Josep Maria Sirvent, Javier A. Menendez, Angel Izquierdo, Rafael Rosell
Publikováno v:
Lung Cancer. 86:102-104
Background Lung cancer is the most common solid tumor in critically ill cancer patients who are admitted to intensive care units (ICUs). An ICU trial consists of unlimited ICU support for a limited time period. Case report We present the case of a 60